Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | UHRF1 | Q96T88 | 1/20 | 0.48 |
| ▸ | CCR1 | P32246 | 1/20 | 0.48 |
| ▸ | CCR5 | P51681 | 1/20 | 0.48 |
| ▸ | CCR8 | P51685 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.45 |
| ▸ | MEN1 | O00255 | 3/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | NOS3 | P29474 | 1/20 | 0.45 |
| ▸ | NOS1 | P29475 | 1/20 | 0.45 |
| ▸ | NOS2 | P35228 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 6/20 | 0.41 |
| ▸ | RAB9A | P51151 | 6/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.41 |
| ▸ | PKM | P14618 | 3/20 | 0.41 |
| ▸ | TP53 | P04637 | 2/20 | 0.41 |
| ▸ | CTSA | P10619 | 2/20 | 0.41 |
| ▸ | PLAU | P00749 | 1/20 | 0.41 |
| ▸ | KDM6B | O15054 | 1/20 | 0.41 |
| ▸ | TET3 | O43151 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29971476 | 1.00 | ALDH1A1 (0.52) | ALDH1A1UHRF1CCR1CCR5CCR8 | |
| SCHEMBL29758442 | 0.83 | KDM4E (0.61) | ALDH1A1UHRF1CCR1CCR5CCR8 | |
| SCHEMBL111587 | 0.83 | KDM4E (0.61) | ALDH1A1UHRF1CCR1CCR5CCR8 | |
| SCHEMBL23019932 | 0.81 | UHRF1 (0.46) | ALDH1A1UHRF1CCR1CCR5CCR8 | |
| SCHEMBL2272913 | 0.81 | KDM4E (0.59) | ALDH1A1UHRF1CCR1CCR5CCR8 | |
| SCHEMBL29503141 | 0.81 | CCR1 (0.52) | UHRF1CCR1CCR5CCR8KDM4E | |
| SCHEMBL5635022 | 0.81 | UHRF1 (0.46) | ALDH1A1UHRF1CCR1CCR5CCR8 | |
| SCHEMBL14037108 | 0.81 | UHRF1 (0.46) | ALDH1A1UHRF1CCR1CCR5CCR8 | |
| SCHEMBL106576 | 0.81 | CCR1 (0.52) | UHRF1CCR1CCR5CCR8KDM4E | |
| SCHEMBL15201526 | 0.80 | CCR1 (0.57) | ALDH1A1UHRF1CCR1CCR5CCR8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 313 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116540465-B | Electrochromic ion storage layer film and preparation method thereof | NINGBO MI RUO ELECTRONIC TECHNOLOGY Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | claimed |
| CN-118130691-A | Method for detecting characteristic components of typical aroma in main stream smoke of cigarettes | 上海烟草集团有限责任公司 | 2024-06-04 | — | — | CN | claimed |
| WO-2024046712-A1 | METHOD FOR PRODUCING A MATERIAL FOR A MEMBRANE, MATERIAL, MEMBRANE AND USE OF A MEMBRANE | Forschungszentrum Jülich GmbH (DE) | 2024-03-07 | — | — | WO | claimed |
| CN-116540465-A | Novel electrochromic ion storage layer film and preparation method thereof | 宁波祢若电子科技有限公司 | 2023-08-04 | — | — | CN | claimed |
| CN-113215861-A | Baked sweet and fragrant cigarette paper and preparation method thereof | 河南中烟工业有限责任公司 | 2021-08-06 | — | — | CN | claimed |
| CN-110423234-B | Thiosemicarbazone derivative containing indole fragment and preparation method and application thereof | 郑州大学 | 2020-06-30 | — | — | CN | claimed |
| CN-110423234-A | Thiosemicarbazone derivative of the segment containing indoles and its preparation method and application | UNIV ZHENGZHOU | 2019-11-08 | — | — | CN | claimed |
| CN-106146390-A | The synthetic method of medicine intermediate 2-acetyl-4-(2-methyl) pyridine | 无锡乾浩生物医药有限公司 | 2016-11-23 | — | — | CN | claimed |
| CN-104313076-A | Method for producing methylpyridinyl ethanol through biological catalysis | UNIV QINGDAO SCIENCE & TECHNOLOGY | 2015-01-28 | — | — | CN | claimed |
| US-20080254130-A1 | Skin Antiaging & Brightening via Multi-function Treatment of Enzyme Dysfunction | BIODERM RESEARCH (US) | 2008-10-16 | — | — | US | claimed |
| US-20060074108-A1 | Matrix metalloprotease (MMP) inhibitors and their application in cosmetic and pharmaceutical composition | BIODERM RESEARCH (US) | 2006-04-06 | — | — | US | claimed |
| CN-116540465-B | Electrochromic ion storage layer film and preparation method thereof | NINGBO MI RUO ELECTRONIC TECHNOLOGY Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | disclosed |
| EP-4705296-A1 | HETEROARYLINDOLE INHIBITORS OF APOL-1 | OmniAB, Inc. (US) | 2026-03-11 | — | — | EP | disclosed |
| US-20260055113-A1 | HETEROARYL COMPOUNDS FOR THE TREATMENT OF CANCER | HOFFMANN-LA ROCHE INC. (US) | 2026-02-26 | — | — | US | disclosed |
| US-12509446-B2 | FYN and VEGFR2 kinase inhibitors | ROTTAPHARM BIOTECH S.R.L. (IT) | 2025-12-30 | — | — | US | disclosed |
| EP-1065206-A1 | Tetrazolylalkyl indole compounds as anti-inflammatory and analgesic agents | PFIZER INC. (US) | 2001-01-03 | — | — | EP | disclosed |
| EP-1045833-A1 | 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS | PFIZER INC. (US) | 2000-10-25 | — | — | EP | disclosed |
| WO-2000049015-A1 | PYRIDINE COMPOUNDS AND THEIR PHARMACEUTICAL USE | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-08-24 | — | — | WO | disclosed |
| EP-0974602-A1 | Catalyst and process for hydrogenating olefinically unsaturated compound | JSR Corporation (JP) | 2000-01-26 | — | — | EP | disclosed |
| WO-1999035130-A1 | 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS | PFIZER PHARMACEUTICALS INC. (JP) | 1999-07-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260055113-A1 | HETEROARYL COMPOUNDS FOR THE TREATMENT OF CANCER | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, HCCS, CLIC1 | ALDH1A1 259/4885UHRF1 3902/4885CCR1 6/4885 |
| US-12509446-B2 | FYN and VEGFR2 kinase inhibitors | FYN, LCK, LYN | ALDH1A1 4279/4885UHRF1 1614/4885CCR1 949/4885 |
| US-20080254130-A1 | Skin Antiaging & Brightening via Multi-function Treatment of Enzyme Dysfunction | PSMB1, PLOD3, CUTA | ALDH1A1 330/4885UHRF1 244/4885CCR1 4807/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.